InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,183.20
(
0.71%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.52
(
-0.11%
)
Bitcoin
59,300.70
(
-0.09%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: opportunityknocking post# 25939

Wednesday, 03/03/2010 1:42:17 PM

Wednesday, March 03, 2010 1:42:17 PM

Post# of 30387
Opportunity, I notice you did not cite the below statements that were included in the BioCurex press release you quoted.

"The development of the point of care test using RECAF technology will take time given the need to perfect the technique and instrument design. There is no assurance the Company will be successful in developing this test, or that the market for this test is anywhere near the size estimated."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up